Sorrento Therapeutics competitors include Alnylam Pharmaceuticals and Coherus BioSciences. Sorrento Therapeutics ranks 2nd in CEO Score on Comparably vs its competitors. See below how Sorrento Therapeutics compares to its competitors with CEO Rankings, Overall Culture Score, eNPS, Gender and Diversity Scores.


10 Employees at Sorrento Therapeutics rate Henry Ji a 60 out of 100, which ranks them 2nd below Alnylam Pharmaceuticals' CEO,John Maraganore. Last rating was months ago.
11 Employees rate Sorrento Therapeutics' Overall Culture a 65/100, which ranks it 2nd against its competitors, below Alnylam Pharmaceuticals. Overall Culture scores are aggregated from all of the questions employees at a company answer on Comparably.
10 Employees rate Sorrento Therapeutics' Employee Net Promoter Score a -30, which ranks it 2nd against its competitors, below Alnylam Pharmaceuticals. Employee Net Promoter score tracks employees' overall score to this question - “On a scale from 0-10, how likely are you to recommend working at Sorrento Therapeutics to a friend?”.
